Clinical outcome comparison between TIPS and EBL in patients with cirrhosis and portal vein thrombosis

Abdominal Imaging

Volumn 40, Issue 6, 2015, Pages 1813-1820

  Wang, Zhu ^a   Zhao, He ^a   Wang, Xiaoze ^a   Zhang, Hailong ^a   Jiang, Mingshan ^a   Tsauo, Jiaywei ^a   Luo, Xuefeng ^a   Yang, Li ^a   Li, Xiao ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Portal hypertension; Portal vein thrombosis; Variceal bleeding

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGE; ANTICOAGULANT THERAPY; ARTICLE; BALLOON CATHETER; CANCER SURVIVAL; CHILD PUGH SCORE; CLINICAL ARTICLE; CONTROLLED STUDY; DIGESTIVE SURGICAL EQUIPMENT; DISEASE EXACERBATION; DISEASE SEVERITY; ENDOSCOPIC BAND LIGATION; ENDOSCOPIC SURGERY; EPIGASTRIC PAIN; FEMALE; FEVER; FOLLOW UP; GENDER; HUMAN; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; SPLENECTOMY; STENT; SURVIVAL RATE; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT OUTCOME; AGED; COMPLICATION; ENDOSCOPY; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HYPERTENSION, PORTAL; LIGATION; MIDDLE AGED; PORTAL VEIN; PROCEDURES; RECURRENT DISEASE; VENOUS THROMBOSIS;

ADULT; AGED; ENDOSCOPY; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; LIGATION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTAL VEIN; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RECURRENCE; RETROSPECTIVE STUDIES; VENOUS THROMBOSIS;

EID: 84938949684     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-014-0320-9     Document Type: Article

References (20)

1. Zocco MA, Di Stasio E, De Cristofaro R, et al. (2009) Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 51(4):682–689
2. Maruyama H, Okugawa H, Takahashi M, Yokosuka O (2013) De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol 108(4):568–574
3. Amitrano L, Guardascione MA, Brancaccio V, et al. (2004) Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 40(5):736–741
4. Liatsos C, Vlachogiannakos J, Patch D, et al. (2001) Successful recanalization of portal vein thrombosis before liver transplantation using transjugular intrahepatic portosystemic shunt. Liver Transpl 7(5):453–460
5. Rodriguez-Castro KI, Porte RJ, Nadal E, et al. (2012) Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review. Transplantation 94:1145–1153
6. Bauer J, Johnson S, Durham J, et al. (2006) The role of TIPS for portal vein patency in liver transplant patients with portal vein thrombosis. Liver Transpl 12(10):1544–1551
7. de Franchis R, Baveno VF (2010) Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 53(4):762–768
8. Luca A, Miraglia R, Caruso S, et al. (2011) Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut 60(6):846–852
9. Han G, Qi X, He C, et al. (2011) Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol 54(1):78–88
10. Van Ha TG, Hodge J, Funaki B, et al. (2006) Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis. Cardiovasc Intervent Radiol 29(5):785–790
11. Senzolo M, Tibbals J, Cholongitas E, et al. (2006) Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther 23(6):767–775
12. Pomier-Layrargues G, Villeneuve JP, Deschenes M, et al. (2001) Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut 48(3):390–396
13. Gulberg V, Schepke M, Geigenberger G, et al. (2002) Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial. Scand J Gastroenterol 37(3):338–343
14. D’Avola D, Bilbao JI, Zozaya G, et al. (2012) Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation. Transplant Proc 44(9):2603–2605
15. Blum U, Haag K, Rossle M, et al. (1995) Noncavernomatous portal vein thrombosis in hepatic cirrhosis: treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis. Radiology 195(1):153–157
16. Zizka J, Elias P, Krajina A, et al. (2000) Value of Doppler sonography in revealing transjugular intrahepatic portosystemic shunt malfunction: a 5-year experience in 216 patients. AJR Am J Roentgenol 175(1):141–148
17. Foshager MC, Ferral H, Nazarian GK, Castaneda-Zuniga WR, Letourneau JG (1995) Duplex sonography after transjugular intrahepatic portosystemic shunts (TIPS): normal hemodynamic findings and efficacy in predicting shunt patency and stenosis. AJR Am J Roentgenol 165(1):1–7
18. Qi X, Chen H, Han G (2013) Effect of antithrombin, protein C and protein S on portal vein thrombosis in liver cirrhosis: a meta-analysis. Am J Med Sci 346(1):38–44
19. Rossle M, Deibert P, Haag K, et al. (1997) Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 349(9058):1043–1049
20. Sauer P, Hansmann J, Richter GM, Stremmel W, Stiehl A (2002) Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial. Endoscopy 34(9):690–697